Attached files

file filename
EX-32.1 - EX-32.1 - Editas Medicine, Inc.ex-32d1.htm
EX-31.2 - EX-31.2 - Editas Medicine, Inc.ex-31d2.htm
EX-31.1 - EX-31.1 - Editas Medicine, Inc.ex-31d1.htm
EX-10.31 - EX-10.31 - Editas Medicine, Inc.ex-10d31.htm
EX-10.30 - EX-10.30 - Editas Medicine, Inc.ex-10d30.htm
EX-10.25 - EX-10.25 - Editas Medicine, Inc.ex-10d25.htm
EX-10.21 - EX-10.21 - Editas Medicine, Inc.ex-10d21.htm
EX-10.20 - EX-10.20 - Editas Medicine, Inc.ex-10d20.htm
EX-10.16 - EX-10.16 - Editas Medicine, Inc.ex-10d16.htm
EX-10.15 - EX-10.15 - Editas Medicine, Inc.ex-10d15.htm
EX-10.14 - EX-10.14 - Editas Medicine, Inc.ex-10d14.htm
EX-10.13 - EX-10.13 - Editas Medicine, Inc.ex-10d13.htm
EX-4.2 - EX-4.2 - Editas Medicine, Inc.ex-4d2.htm
10-K - 10-K - Editas Medicine, Inc.edit-20191231x10k624cb2.htm

Exhibit 23.1

 

Consent of Independent Registered Public Accounting Firm

 

We consent to the incorporation by reference in the following Registration Statements:

 

(1)

Registration Statements (Form S-3 No. 333-216528, 333-222266, and 333-223596) of Editas Medicine, Inc., 

 

(2)

Registration Statement (Form S-8 No. 333-209351) pertaining to the Editas Medicine, Inc. 2013 Stock Incentive Plan, 2015 Stock Incentive Plan and 2015 Employee Stock Purchase Plan, and

 

(3)

Registration Statements (Form S-8 Nos. 333-216445, 333-223529 and 333-230266) pertaining to the 2015 Stock Incentive Plan and 2015 Employee Stock Purchase Plan;

 

of our reports dated February 26, 2020, with respect to the consolidated financial statements of Editas Medicine, Inc. and the effectiveness of internal control over financial reporting of Editas Medicine, Inc., included in this Annual Report (Form 10-K) of Editas Medicine, Inc. for the year ended December 31, 2019.

 

/s/ Ernst & Young LLP

 

Boston, Massachusetts

February 26, 2020